Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

MLA

“Health Canada Approves DOPTELET (Avatrombopag) for Two Indications in Thrombocytopenia.” GlobeNewswire, 6 Nov. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.771648106&authtype=sso&custid=ns315887.

APA

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia. (2023, November 6). GlobeNewswire.

Chicago

GlobeNewswire. 2023. “Health Canada Approves DOPTELET (Avatrombopag) for Two Indications in Thrombocytopenia,” November 6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.771648106&authtype=sso&custid=ns315887.